Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic or Locally Advanced Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00268840
What this trial is testing

The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

Who this might be right for
Pancreatic NeoplasmsBiliary Tract Neoplasms
ARCAGY/ GINECO GROUP 45
Large-scale testing (Phase 3)Looking for participantsNCT06564324
What this trial is testing

A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients

Who this might be right for
Non Small Cell Lung Cancer
Nuvation Bio Inc. 194
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128693
What this trial is testing

A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 60
Early research (Phase 1)Study completedNCT02699515
What this trial is testing

MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumors
Merck KGaA, Darmstadt, Germany 114
Testing effectiveness (Phase 2)Ended earlyNCT00321308
What this trial is testing

Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Pfizer 36
Early research (Phase 1)Looking for participantsNCT05194982
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor

Who this might be right for
Locally Advanced or Metastatic Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 570
Testing effectiveness (Phase 2)Study completedNCT00061659
What this trial is testing

Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Abbott 88
Testing effectiveness (Phase 2)Looking for participantsNCT07114861
What this trial is testing

The KN510713 Study in Combination With mFOLFIRINOX

Who this might be right for
Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
New Cancer Cure-Bio Co.,Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT04521179
What this trial is testing

Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors

Who this might be right for
HER2-positive Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 102
Early research (Phase 1)UnknownNCT05008861
What this trial is testing

Gut Microbiota Reconstruction for NSCLC Immunotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00701870
What this trial is testing

Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Telik 1
Large-scale testing (Phase 3)Study completedNCT00190762
What this trial is testing

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Who this might be right for
Mesothelioma
Eli Lilly and Company 240
Testing effectiveness (Phase 2)Study completedNCT03587662
What this trial is testing

Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Medullary CarcinomaMetastatic Renal Cell CarcinomaSMARCB1 Negative+2 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06348927
What this trial is testing

Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital 52
Testing effectiveness (Phase 2)UnknownNCT05096390
What this trial is testing

Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC

Who this might be right for
Papillary Renal Cell Carcinoma Type 2
Centre Leon Berard 72
Early research (Phase 1)Not Yet RecruitingNCT07587827
What this trial is testing

Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)Locally Advanced Colorectal CancerMetastatic Pancreatic Cancer+1 more
Centre Georges Francois Leclerc 77
Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Testing effectiveness (Phase 2)Looking for participantsNCT05440227
What this trial is testing

PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

Who this might be right for
Cancer-related Fatigue
PhytoHealth Corporation 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07294261
What this trial is testing

Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC

Who this might be right for
Local Advanced or Metastatic NSCLC
Sun Yat-sen University 69
Post-approval studies (Phase 4)Study completedNCT01287754
What this trial is testing

Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 24
Next Page